YOUR BROWSER MUST ALLOW POP-UPS IN ORDER TO LINK TO OTHER WEBSITES OR VIEW PDF FILES.

EraGen BioSciences Inc.
www.eragen.com
EraGen products drive essential molecular diagnostics to market faster by providing clinical laboratories and medical researchers with the next generation of easy-to-use genetic testing for critical disease states including infectious diseases, genetics and cancer. Madison-based Eragen has raised over $20 million in venture capital from investors including Novartis Ventures, First Analysis Corp, Prolog Ventures, Stonehenge Capital and Continuum Investment Partners.

Eso-Technologies, Inc.
www.esotechinc.com

Eso-Technologies is an early stage company developing an esophageal cardiac monitoring device for surgical and critical care applications. This new device is designed to replace the industry standard and more invasive pulmonary artery catheter (PAC), and offer greater capabilities, improved diagnostic specificity, greatly enhanced safety, and significant cost advantages. Wisconsin-based, Eso-Technologies has developed and tested their product prototypes, completed a clinical protocol, and engaged three clinical partners to complete early trials. The company's $1MM Series A Preferred was led by DaneVest with significant participation by Phenomenelle Angels Fund.

HarQen, LLC
www.harqen.com

HarQen is a web telephony company that leverages its voice to web audio technology and social networking platform to develop smart, easy-to-use business applications that solve real world problems. From a consumer standpoint, using HarQen’s technology is as easy as leaving a voicemail. The company's first two products are VoiceScreener and Comic Wonder. Milwaukee-based HarQen's Round One and bridge financing rounds were led by the Phenomenelle Angel Fund, with participation by Wisconsin Investment Partners and Women Angels.

iDC
www.4gov.com

iDC is a leading developer of Fund Accounting software for government and not-for-profit organizations. iDC’s web-based, scalable products are designed for rapid implementation, seamless integration, and can be tailored to fit specific needs of IT, finance and elected officials. They enhance emergency preparedness, government continuity and disaster recovery. iDC recently gained national recognition as recipient of the NAWBO/Wells Fargo Trailblazer Award for Technology Innovation and the 2005 Torch Award for Marketplace Ethics from the Better Business Bureau of Northern Illinois. Additionally, the Illinois Department of Commerce and Economic Opportunity awarded iDC a grant to enhance homeland security efforts. iDC is based in Chicago. Phenomenelle Angel Fund was iDC's first institutional investor.

Michelle's Miracle, Inc.
www.michellesmiracle.com

Michelle’s Miracle® creates, markets and distributes branded products made from tart cherry concentrate as nutritional supplements in the U.S. and Canada through direct, wholesale and private label channels targeted at consumers seeking natural and whole food based solutions for overall health and chronic conditions such as joint pain and arthritis. Leland, Michigan-based Michelle's Miracle's Series A round was led by the Phenomenelle Angels Fund. Seed investor, Fisher Properties of Indiana, reinvested in the company's Series A.

Stemina Biomarker Discovery Inc.
www.stemina.com

Stemina Cell Discovery discovers and validates small molecules as biomarkers for high-throughput drug screening and disease diagnostics using an all human system comprised of stem cells and the Company's proprietary metabolomics platform. Metabolomics enables the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity. The human embryonic stem cell metabolome is a source of candidate biomarkers to predict, diagnose or measure the progress of disease or toxic response. Stemina provides compound screening and diagnostic development for the pharmaceutical and biotechnology industries and academia under contract services or joint discovery agreements. Stemina is based in Madison, WI. Phenomenelle Angels Fund co-invested with Wisconsin Investment Partners and DaneVest Capital.

TrafficCast International Inc.
www.trafficcast.com

TrafficCast International is a leading provider of digital traffic data, with patented software and predictive models to produce route-specific real-time traffic information and travel time forecasts for traditional and emerging traffic information markets. TrafficCast International recently deployed the world's largest cell probe data collection system in Shanghai. The company is based in Madison, Wisconsin and has a branch office in Shanghai. Phenomenelle Angels Fund co-led TrafficCast's Series A round together with NEW Capital Fund and Ceres Ventures.